Nicolas GP - Search Results

1

Cholecystokinin 2 Receptor Agonist ¹⁷⁷Lu-PP-F11N for Radionuclide Therapy of Medullary Thyroid Carcinoma: Results of the Lumed Phase 0a Study.

Rottenburger C, Nicolas GP, McDougall L, Kaul F, Cachovan M, Vija AH, Schibli R, Geistlich S, Schumann A, Rau T, Glatz K, Behe M, Christ ER, Wild D. Rottenburger C, et al. Among authors: nicolas gp. J Nucl Med. 2020 Apr;61(4):520-526. doi: 10.2967/jnumed.119.233031. Epub 2019 Sep 13. J Nucl Med. 2020. PMID: 31519804 Free PMC article. Clinical Trial.

2

Development of new folate-based PET radiotracers: preclinical evaluation of ⁶⁸Ga-DOTA-folate conjugates.

Fani M, Wang X, Nicolas G, Medina C, Raynal I, Port M, Maecke HR. Fani M, et al. Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):108-19. doi: 10.1007/s00259-010-1597-8. Epub 2010 Aug 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 20799032

3

Radiolabeled bicyclic somatostatin-based analogs: a novel class of potential radiotracers for SPECT/PET of neuroendocrine tumors.

Fani M, Mueller A, Tamma ML, Nicolas G, Rink HR, Cescato R, Reubi JC, Maecke HR. Fani M, et al. J Nucl Med. 2010 Nov;51(11):1771-9. doi: 10.2967/jnumed.110.076695. Epub 2010 Oct 18. J Nucl Med. 2010. PMID: 20956465 Free article.

4

Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.

Abiraj K, Mansi R, Tamma ML, Fani M, Forrer F, Nicolas G, Cescato R, Reubi JC, Maecke HR. Abiraj K, et al. J Nucl Med. 2011 Dec;52(12):1970-8. doi: 10.2967/jnumed.111.094375. Epub 2011 Nov 11. J Nucl Med. 2011. PMID: 22080443 Free article.

5

Peptide receptor radionuclide therapy with somatostatin analogues in neuroendocrine tumors.

Giovacchini G, Nicolas G, Forrer F. Giovacchini G, et al. Anticancer Agents Med Chem. 2012 Jun;12(5):526-42. doi: 10.2174/187152012800617803. Anticancer Agents Med Chem. 2012. PMID: 22292758 Review.

6

Acute toxoplasmosis mimicking melanoma metastases: review of conditions causing false-positive results on (18)F-FDG PET/CT.

Ivanova K, Glatz K, Zippelius A, Nicolas G, Itin P. Ivanova K, et al. Dermatology. 2012;225(4):349-53. doi: 10.1159/000346333. Epub 2013 Feb 9. Dermatology. 2012. PMID: 23406996 Review.

7

Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study.

Christ E, Wild D, Ederer S, Béhé M, Nicolas G, Caplin ME, Brändle M, Clerici T, Fischli S, Stettler C, Ell PJ, Seufert J, Gloor B, Perren A, Reubi JC, Forrer F. Christ E, et al. Lancet Diabetes Endocrinol. 2013 Oct;1(2):115-22. doi: 10.1016/S2213-8587(13)70049-4. Epub 2013 Jul 25. Lancet Diabetes Endocrinol. 2013. PMID: 24622317 Free article. Clinical Trial.

8

Localization of Hidden Insulinomas with ⁶⁸Ga-DOTA-Exendin-4 PET/CT: A Pilot Study.

Antwi K, Fani M, Nicolas G, Rottenburger C, Heye T, Reubi JC, Gloor B, Christ E, Wild D. Antwi K, et al. J Nucl Med. 2015 Jul;56(7):1075-8. doi: 10.2967/jnumed.115.157768. Epub 2015 May 21. J Nucl Med. 2015. PMID: 25999434 Free article. Clinical Trial.

9

Peptide Receptor Radionuclide Therapy-Induced Hepatotoxicity in Patients With Metastatic Neuroendocrine Tumors.

Riff BP, Yang YX, Soulen MC, Pryma DA, Bennett B, Wild D, Nicolas G, Teitelbaum UR, Metz DC. Riff BP, et al. Clin Nucl Med. 2015 Nov;40(11):845-50. doi: 10.1097/RLU.0000000000000935. Clin Nucl Med. 2015. PMID: 26284763

10

Gastroenteropancreatic neuroendocrine tumours (GEP-NET) - Imaging and staging.

Baumann T, Rottenburger C, Nicolas G, Wild D. Baumann T, et al. Best Pract Res Clin Endocrinol Metab. 2016 Jan;30(1):45-57. doi: 10.1016/j.beem.2016.01.003. Epub 2016 Jan 20. Best Pract Res Clin Endocrinol Metab. 2016. PMID: 26971843 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

59 results

Search Page

Filters